Zobrazeno 1 - 10
of 1 308
pro vyhledávání: '"Sleeve lobectomy"'
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 1221-1230 (2024)
Yanjun Qiu, Jinjiang Yu, Quanmin Guo, Jingyan Xu Department of Cardiothoracic Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou City, Zhejiang Province, People’s Republic of ChinaCorrespondence: Jingyan Xu, Department of
Externí odkaz:
https://doaj.org/article/a23f2f78196c42baadaecaa9c42625d8
Autor:
Rui Han, Fan Zhang, Qian Hong, Djaferi Visar, Chang Zhan, Chenguang Zhao, Fuquan Wang, Sining Zhang, Fang Li, Jiagen Li, Juwei Mu
Publikováno v:
Thoracic Cancer, Vol 15, Iss 24, Pp 1792-1804 (2024)
Abstract Background The goal of the research was to examine the value of peripheral blood indicators in forecasting survival and recurrence among people suffering central‐type non‐small cell lung cancer (NSCLC) undergoing sleeve lobectomy (SL). M
Externí odkaz:
https://doaj.org/article/3d0e74a772b740f4994a0899a9cb7089
Autor:
Po‐Keng Su, Chen‐Chieh Lin, Szu‐Yen Hu, Ming‐Hsien Lin, Chun‐Yu Wu, Shun‐Mao Yang, Takahiro Oto
Publikováno v:
Respirology Case Reports, Vol 12, Iss 10, Pp n/a-n/a (2024)
Abstract Sleeve and double‐sleeve lobectomies are lung‐sparing techniques for treating central lung cancers. However, if the tumour extends to involve the bronchi and vessels, lung auto‐transplantation may be an alternative to pneumonectomy. Ne
Externí odkaz:
https://doaj.org/article/a0f960d9ba574e478c3b31c4328469a7
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 21, Iss 2, Pp 99-101 (2024)
Externí odkaz:
https://doaj.org/article/3c4a410e66574141afd8603fc3ab8d26
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 5, Pp 2438-2440 (2024)
Externí odkaz:
https://doaj.org/article/4696f8a06e314d0c8d9b4c334e93d4c7
Autor:
Kajetan Kiełbowski, Piotr Ostrowski, Michał Kubisa, Jarosław Pieróg, Janusz Wójcik, Bartosz Kubisa
Publikováno v:
Folia Medica, Vol 65, Iss 2, Pp 311-315 (2023)
Lung cancer is a leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is a predominant subtype and treatment may include immunotherapy, radiotherapy, chemotherapy, and surgery. Tumors of bigger size infiltrating large
Externí odkaz:
https://doaj.org/article/0c2b3104d288417db5d2a9deaecfbaab
Autor:
Tao Chen, PhD, Yifan Zhong, PhD, Jialiang Wen, PhD, Jiajun Deng, PhD, Yunlang She, MD, Yuming Zhu, MD, Qiankun Chen, MD, Chunyan Wu, MD, Likun Hou, MD, Lei Jiang, MD, Chang Chen, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100574- (2023)
Introduction: To validate the residual tumor (R) classification proposed by the International Association for the Study of Lung Cancer (IASLC) in NSCLC after sleeve lobectomy. Methods: A total of 682 patients were analyzed. The R status, on the basis
Externí odkaz:
https://doaj.org/article/0a835e6f1c6d449383cdecf66c51ba1a
Autor:
Tsubasa Matsuo, Kazuhiro Imai, Shinogu Takashima, Nobuyasu Kurihara, Shoji Kuriyama, Hidenobu Iwai, Kasumi Tozawa, Hajime Saito, Kyoko Nomura, Yoshihiro Minamiya
Publikováno v:
Thoracic Cancer, Vol 14, Iss 9, Pp 827-833 (2023)
Abstract Background Sleeve lobectomy is recommended to avoid pneumonectomy and preserve pulmonary function in patients with central lung cancer. However, the relationship between postoperative pulmonary functional loss and resected lung parenchyma vo
Externí odkaz:
https://doaj.org/article/0693dea7ca7041de868761e5afc7348f
Autor:
Baihua Zhang, Haifan Xiao, Xingxiang Pu, Chunhua Zhou, Desong Yang, Xu Li, Wenxiang Wang, Qin Xiao
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 274-286 (2023)
Abstract Background The impact of neoadjuvant chemoimmunotherapy on pulmonary resection and related outcomes had been poorly reported in previous studies. The present study aims to clarify the efficacy and safety of neoadjuvant chemoimmunotherapy, an
Externí odkaz:
https://doaj.org/article/8925d5cd30b94bb1be82332c05d4df55
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.